FDA authorizes Merck's at-home antiviral COVID-19 pill
Merck's drug molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30%.
Full Article
FDA authorizes Merck's at-home antiviral COVID-19 pill
Jerusalem Post
0 shares
1 views
You might like
Related news coverage
U.S. Adds Merck Pill As 2nd Easy-To-Use Drug Against COVID-19
Newsy
Watch VideoU.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication..
Advertisement
More coverage
Pfizer Confirms COVID Pill's Results, Potency Against Omicron
Newsy
Watch VideoPfizer said Tuesday that its experimental COVID-19 pill appears effective against the Omicron variant.
The..
